Efficacy of budesonide/formoterol powder for inhalation in treatment of patients with bronchial asthma
- VernacularTitle:布地奈德／福莫特罗干粉吸入治疗支气管哮喘的临床效果观察
- Author:
Haizhen JIN
;
Jiyang ZHENG
;
Xinjian DAI
;
Qiong CHI
;
Wantie WANG
- Publication Type:Journal Article
- Keywords:
budesonide/formoterol powder;
inhalation therapy;
bronchial asthma
- From:
Chinese Journal of Biochemical Pharmaceutics
2015;(12):100-101
- CountryChina
- Language:Chinese
-
Abstract:
Objective To observe the clinical effect of therapy of budesonide/formoterol powder for inhalation in treatment of adult with bronchial asthma.Methods 90 cases with bronchial asthma and were divided into observation group and control group randomly from February 2014 to February 2015.45 cases in each group.Control group was treated with budesonide inhalants +formoterol inhalants, observation group was given budesonide/formoterol powder inhalation.Changes of related indicators were followed up and recorded.Results After treatment, IL-5, IL-12 and IFN-γwere (60.2 ±9.7)pg/mL,(31.4 ±3.1)pg/mL,(1.6 ±0.2) ng/mL of observation group were better than control group (72.8 ±10.7)pg/mL,(38.5 ± 5.6)pg/mL,(2.3 ±0.3) ng/mL (P<0.05).After treatment,total effective rate in observation group was 68.9%, which was better than control group (48.9%)(P<0.05).Conclusion Clinical effect of budesonide/formoterol powder for inhalation in treatment of patients with bronchial asthma is accurate, and there is no obvious adverse reaction.
